Causative Pathogens in Endophthalmitis after Intravitreal Injection of Anti-vascular Endothelial Growth Factor Agents

about

Causative Pathogens in Endophthalmitis after Intravitreal Injection of Anti-vascular Endothelial Growth Factor Agents

Item

http://www.wikidata.org/entity/Q58784488

description

wetenschappelijk artikel

@nl

наукова стаття, опублікована у вересні 2018

@uk

name

Causative Pathogens in Endopht ...... dothelial Growth Factor Agents

@en

Causative Pathogens in Endopht ...... dothelial Growth Factor Agents

@nl

type

Item

label

Causative Pathogens in Endopht ...... dothelial Growth Factor Agents

@en

Causative Pathogens in Endopht ...... dothelial Growth Factor Agents

@nl

prefLabel

Causative Pathogens in Endopht ...... dothelial Growth Factor Agents

@en

Causative Pathogens in Endopht ...... dothelial Growth Factor Agents

@nl

P1476

Causative Pathogens in Endopht ...... dothelial Growth Factor Agents

@en

P2093

Cecilia P Labardini

http://www.w3.org/2001/XMLSchema#string

Eytan Z Blumenthal

http://www.w3.org/2001/XMLSchema#string

P2860

Surgical hand antisepsis to reduce surgical site infection

Endophthalmitis following intravitreal anti-vascular endothelial growth factor (VEGF) injection: a comprehensive review

Risk of endophthalmitis after intravitreal drug injection when topical antibiotics are not required: the diabetic retinopathy clinical research network laser-ranibizumab-triamcinolone clinical trials.

Indigenous flora from human saliva.

Povidone-iodine before lidocaine gel anesthesia achieves surface antisepsis.

Uveitis following intravitreal bevacizumab: a non-infectious cluster.

Effect of lidocaine gel anesthesia on endophthalmitis rates following intravitreal injection.

Meta-analysis of infectious endophthalmitis after intravitreal injection of anti-vascular endothelial growth factor agents.

Current Infectious Endophthalmitis Rates After Intravitreal Injections of Anti-Vascular Endothelial Growth Factor Agents and Outcomes of Treatment.

Effect of a Strict 'No-Talking' Policy During Intravitreal Injection on Post-Injection Endophthalmitis.

P304

1-6

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.5041/RMMJ.10348

http://www.w3.org/2001/XMLSchema#string

P407

English

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P577

2018-09-02T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

30180932

http://www.w3.org/2001/XMLSchema#string

P932

6185999

http://www.w3.org/2001/XMLSchema#string